Bionoid Pharma Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Wednesday, Jan 8, 2025 7:51 am ET

Bionoid Pharma, Inc. (OTC PINK:BINP) has announced a significant milestone in its expansion into the health and wellness e-commerce sector. The company has generated over $100,000 in revenue following the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store Ltd. This achievement underscores Bionoid's strategic growth strategy and its ability to drive results even before completing the acquisition process.
Under the terms of the LOI, Bionoid retains all revenue generated during the transition period prior to the signing of the final Asset Purchase Agreement (APA). This structure enables the company to capture immediate value while ensuring a seamless integration process. The acquisition of Your Supplement Supply Store Ltd.'s leading e-commerce platform, EnhancedSupplements.net, is expected to strengthen Bionoid's presence in the e-commerce space and propel growth within the health and wellness market.
Wayne Cockburn, CEO of Bionoid Pharma, Inc., commented on the revenue milestone, stating, "The revenue generated from this agreement is a testament to the strength of our strategic partnerships and our ability to drive results even before completing the acquisition process. This success reinforces our commitment to building a robust e-commerce presence in the health and wellness sector and highlights the potential for future growth as we continue to execute our long-term vision."
Bionoid's strategy focuses on acquiring high-value e-commerce platforms and leveraging its proprietary AI Maverick technology to optimize customer engagement and operational efficiency. The success of this initial revenue generation further positions the company as a leader in the health and wellness market.
In conclusion, Bionoid Pharma, Inc.'s revenue milestone of over $100,000 following the signing of a Binding Letter of Intent with Your Supplement Supply Store Ltd. aligns with the company's long-term growth strategy. By leveraging strategic acquisitions and advanced AI technology, Bionoid is well-positioned to drive growth and expand its presence in the health and wellness e-commerce sector. As the company continues to execute its long-term vision, investors can expect to see further progress and potential for future growth.